Histotype
Lymphoma [B-Cell]
| Parameter | Information |
|---|---|
| Strain | Balb/c |
| Implant Type | Cells |
| Implant Location | IV |
| Time to Staging | 7 days |
| Time to 750mm³ | 17.6 days |
| Td | 2.4 days |
The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact us.
Tumor Line
Mouse
Ref #
9203
Spotlight on A20-LUC2-PURO
Learn more about this cell line in our scientific spotlights:
Lymphomas represent a set of lymphoid cell malignancies that can range from indolent to aggressive. B cell-derived lymphomas, specifically non-Hodgkin lymphoma (NHL), are the most prevalent, but this disease can also originate from T cells. In 2018, an estimated 74,680 new cases of NHL in the United States will be diagnosed, and 19,910 patient deaths will occur. While the five-year survival rate for NHL is relatively high at 71%,[1] recurrence is common, so continued discovery of improved treatments for lymphoma is important for long term survival of these patients.